Sign Up to like & get
recommendations!
1
Published in 2019 at "International Journal of Cancer"
DOI: 10.1002/ijc.32419
Abstract: Malignant pleural mesothelioma (MPM) is a tumor with high chemoresistance and poor prognosis. MPM‐initiating cells (ICs) are known to be drug resistant, but it is unknown if and how stemness‐related pathways determine chemoresistance. Moreover, there…
read more here.
Keywords:
mpm;
chemoresistance;
mesothelioma;
abcb5 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Cancer Research"
DOI: 10.1158/1538-7445.am2018-2448
Abstract: Cellular oxidative stress is characterized by elevated reactive oxygen species (ROS), and is a frequent phenotype of cancer cells. The consequences of ROS are complex, where ROS can promote or inhibit tumorigenesis. In mesothelioma, asbestos…
read more here.
Keywords:
cell survival;
mesothelioma;
cisplatin pemetrexed;
drug ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Case Reports in Oncology"
DOI: 10.1159/000460244
Abstract: This report presents the case of a 60-year-old woman who was diagnosed with stage IV lung adenocarcinoma with asymptomatic brain metastases and commenced chemotherapy with cisplatin/pemetrexed (CDDP/Pem). She experienced tonic-clonic convulsions on day 9 of…
read more here.
Keywords:
encephalopathy syndrome;
posterior reversible;
case;
cisplatin pemetrexed ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.tps8582
Abstract: TPS8582Background: For patients (pts) with stage IB (≥4cm)-IIIA Non-small-cell lung cancer (NSCLC), multi-modality therapy yields a modest improvement in 5 year post-surgical overall survival (OS),...
read more here.
Keywords:
cisplatin gemcitabine;
gemcitabine induction;
cisplatin pemetrexed;
nivolumab plus ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.e20069
Abstract: e20069 Background: Malignant pleural mesothelioma (MPM) is an aggressive thoracic cancer mostly linked to asbestos exposure. The standard of care (SOC) therapy for unresectable MPM is cisplatin plus pemetrexed. Treating Fields (TTFields) therapy is an…
read more here.
Keywords:
ttfields cisplatin;
150 khz;
treatment;
combined treatment ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.22.02544
Abstract: PURPOSE Cisplatin plus gemcitabine is a standard regimen for first-line treatment of advanced non–small-cell lung cancer (NSCLC). Phase II studies of pemetrexed plus platinum compounds have also shown activity in this setting. PATIENTS AND METHODS…
read more here.
Keywords:
oncology;
cell;
cisplatin pemetrexed;
phase ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "AntiCancer Research"
DOI: 10.21873/anticanres.15677
Abstract: Aim: This study compared the results of nivolumab treatment in patients with pulmonary adenocarcinomas based upon previous chemotherapeutic regimens. Patients and Methods: The data source for this retrospective study was the Czech VILP registry of…
read more here.
Keywords:
cisplatin pemetrexed;
vinorelbine;
treatment;
line ... See more keywords